Fig. 2
From: TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
Diagram of multiple immune activation cascades upon treatment with PS-targeting mAb. Proposed pathways altered by PS-targeting mAbs that could result in improved anti-tumor immune activity